Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SEMA3G anticorps (Middle Region)

SEMA3G Reactivité: Humain WB, IHC (p), EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN954720
  • Antigène Voir toutes SEMA3G Anticorps
    SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))
    Épitope
    • 9
    • 7
    • 6
    • 6
    • 3
    AA 223-252, Middle Region
    Reactivité
    • 28
    • 1
    Humain
    Hôte
    • 26
    • 2
    Lapin
    Clonalité
    • 28
    Polyclonal
    Conjugué
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SEMA3G est non-conjugé
    Application
    • 19
    • 15
    • 14
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
    Specificité
    Recognizes SEMA3G (Center).
    Purification
    Protein A column followed by peptide Affinity purification
    Immunogène
    KLH conjugated synthetic peptide between 223-252 amino acids from the Central region of Human SEMA3G Genename: SEMA3G
    Isotype
    Ig Fraction
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS with 0.09 % (W/V) Sodium Azide as preservative
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Thal, Züchner, Gierer, Schulte, Schöls, Schüle, Synofzik: "Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation." dans: International journal of molecular sciences, Vol. 16, Issue 10, pp. 25050-66, (2016) (PubMed).

    Franke, Rickelt, Zimbelmann, Dörflinger, Kuhn, Frey, Heid, Rosin-Arbesfeld et al.: "Striatins as plaque molecules of zonulae adhaerentes in simple epithelia, of tessellate junctions in stratified epithelia, of cardiac composite junctions and of various size classes of lateral ..." dans: Cell and tissue research, Vol. 359, Issue 3, pp. 779-97, (2015) (PubMed).

    Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." dans: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

    Karayan-Tapon, Wager, Guilhot, Levillain, Marquant, Clarhaut, Potiron, Roche: "Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?" dans: British journal of cancer, Vol. 99, Issue 7, pp. 1153-60, (2008) (PubMed).

    Kigel, Varshavsky, Kessler, Neufeld: "Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells." dans: PLoS ONE, Vol. 3, Issue 9, pp. e3287, (2008) (PubMed).

    Rikova, Guo, Zeng, Possemato, Yu, Haack, Nardone, Lee, Reeves, Li, Hu, Tan, Stokes, Sullivan, Mitchell, Wetzel, Macneill, Ren, Yuan, Bakalarski, Villen, Kornhauser, Smith, Li, Zhou, Gygi, Gu et al.: "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. ..." dans: Cell, Vol. 131, Issue 6, pp. 1190-203, (2007) (PubMed).

    Howell, Shindo, Murray, Gridley, Wilson, Schimenti: "Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations." dans: Genetics, Vol. 175, Issue 2, pp. 699-707, (2007) (PubMed).

    Fukuda, Mikoshiba: "Tac2-N, an atypical C-type tandem C2 protein localized in the nucleus." dans: FEBS letters, Vol. 503, Issue 2-3, pp. 217-8, (2001) (PubMed).

  • Antigène
    SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))
    Autre désignation
    SEMA3G (SEMA3G Produits)
    Synonymes
    anticorps sem2, anticorps AK129018, anticorps CSG53, anticorps RGD1306079, anticorps semaphorin 3G, anticorps sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G, anticorps SEMA3G, anticorps Sema3g, anticorps sema3g
    Sujet
    SEMA3G has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity).Synonyms: Semaphorin sem2, Semaphorin-3G
    ID gène
    56920
    NCBI Accession
    NP_064548
Vous êtes ici:
Support technique